Prelude Capital Management’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,785
Closed -$208K 1276
2023
Q3
$208K Buy
+2,785
New +$247K 0.02% 875
2020
Q4
Sell
-503
Closed -$83K 1818
2020
Q3
$83K Buy
503
+283
+129% +$46.6K 0.01% 971
2020
Q2
$31K Buy
+220
New +$20.2K ﹤0.01% 1280
2020
Q1
Sell
-22,671
Closed -$2.48M 1917
2019
Q4
$2.48M Buy
+22,671
New +$2.19M 0.32% 173
2019
Q2
Sell
-100
Closed -$13K 2023
2019
Q1
$13K Sell
100
-36
-26% -$4.57K ﹤0.01% 1379
2018
Q4
$17K Sell
136
-224
-62% -$38.3K ﹤0.01% 1269
2018
Q3
$80K Sell
360
-945
-72% -$192K 0.01% 1012
2018
Q2
$209K Buy
1,305
+8
+0.6% +$1.02K 0.02% 743
2018
Q1
$121K Buy
1,297
+395
+44% +$29.5K 0.01% 819
2017
Q4
$63K Buy
902
+283
+46% +$18.8K 0.01% 889
2017
Q3
$37K Buy
+619
New +$30.8K ﹤0.01% 1181
2017
Q1
Sell
-2,052
Closed -$85K 1671
2016
Q4
$85K Sell
2,052
-1,687
-45% -$67.9K 0.01% 882
2016
Q3
$141K Sell
3,739
-4,461
-54% -$160K 0.02% 688
2016
Q2
$273K Buy
8,200
+7,300
+811% +$236K 0.04% 410
2016
Q1
$27K Sell
900
-1,800
-67% -$52.6K ﹤0.01% 1074
2015
Q4
$82K Sell
2,700
-800
-23% -$23.8K 0.01% 883
2015
Q3
$94K Sell
3,500
-3,450
-50% -$100K 0.02% 860
2015
Q2
$225K Sell
6,950
-3,150
-31% -$99.9K 0.03% 541
2015
Q1
$303K Buy
10,100
+8,900
+742% +$282K 0.04% 493
2014
Q4
$40K Buy
1,200
+300
+33% +$9.34K 0.01% 1369
2014
Q3
$30K Sell
900
-1,700
-65% -$52.2K ﹤0.01% 1643
2014
Q2
$79K Buy
+2,600
New +$81K 0.01% 1199
2014
Q1
Sell
-3,844
Closed -$100K 2031
2013
Q4
$100K Buy
3,844
+2,744
+249% +$70.3K 0.02% 841
2013
Q3
$30K Buy
+1,100
New +$29.4K 0.01% 1130

Other funds holding MED